| Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 344.87 mm | 344.87 mm | 344.87 mm | 344.87 mm | 344.87 mm | 344.87 mm |
| Cash burn (monthly) | 9.70 mm | 1.12 mm | (no burn) | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | 20.18 mm | 2.33 mm | n/a | n/a | n/a | n/a |
| Cash remaining | 324.68 mm | 342.53 mm | n/a | n/a | n/a | n/a |
| Runway (months of cash) | 33.5 | 305.3 | n/a | n/a | n/a | n/a |
| 13F holders | Current |
|---|---|
| Total holders | 267 |
| Opened positions | 36 |
| Closed positions | 54 |
| Increased positions | 93 |
| Reduced positions | 96 |
| 13F shares | Current |
|---|---|
| Total value | 4.15 tn |
| Total shares | 29.55 mm |
| Total puts | 233.00 k |
| Total calls | 387.90 k |
| Total put/call ratio | 0.6 |
| Largest owners | Shares | Value |
|---|---|---|
| FMR | 4.31 mm | $675.83 bn |
| BlackRock | 4.03 mm | $631.95 bn |
| Vanguard | 2.88 mm | $450.94 bn |
| Avoro Capital Advisors | 2.63 mm | $411.83 bn |
| STT State Street | 1.28 mm | $200.36 bn |
| Sun Pharma | 914.11 k | $78.12 mm |
| Frazier Life Sciences IX | 895.00 k | $53.70 mm |
| Capital World Investors | 879.20 k | $137.74 bn |
| Frazier Life Sciences Management | 788.46 k | $123.52 bn |
| Redmile | 753.18 k | $117.99 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 28 Feb 25 | Krish S Krishnan | Common Stock | Payment of exercise | Dispose F | Yes | No | 179.25 | 10,414 | 1.87 mm | 1,491,997 |
| 28 Feb 25 | Krish S Krishnan | Common Stock | Option exercise | Acquire M | Yes | No | 0 | 22,500 | 0.00 | 1,502,411 |
| 28 Feb 25 | Krish S Krishnan | Common Stock | Payment of exercise | Dispose F | Yes | No | 179.25 | 3,471 | 622.18 k | 1,479,911 |
| 28 Feb 25 | Krish S Krishnan | Common Stock | Option exercise | Acquire M | Yes | No | 0 | 7,500 | 0.00 | 1,483,382 |
| 28 Feb 25 | Krish S Krishnan | Common Stock | Payment of exercise | Dispose F | No | No | 179.25 | 12,149 | 2.18 mm | 1,558,056 |
| 28 Feb 25 | Krish S Krishnan | Common Stock | Option exercise | Acquire M | No | No | 0 | 26,250 | 0.00 | 1,570,205 |
| 28 Feb 25 | Krish S Krishnan | Common Stock | Payment of exercise | Dispose F | No | No | 179.25 | 4,050 | 725.96 k | 1,543,955 |
| 28 Feb 25 | Krish S Krishnan | Common Stock | Option exercise | Acquire M | No | No | 0 | 8,750 | 0.00 | 1,548,005 |
| 28 Feb 25 | Krish S Krishnan | Common Stock | Payment of exercise | Dispose F | No | No | 179.25 | 5,786 | 1.04 mm | 1,539,255 |
| 28 Feb 25 | Krish S Krishnan | Common Stock | Option exercise | Acquire M | No | No | 0 | 12,500 | 0.00 | 1,545,041 |
